NCT04099121

Brief Summary

Symptoms of female pelvic floor dysfunction, such as incontinence and pelvic organ prolapse, can be alleviated by using pessaries, which are passive medical devices that are inserted in the vagina to support the pelvic organs. Currently, pessaries are fit through trial and error after manual examination, the accuracy of which depends on the physician's expertise level. The objective of this study is to evaluate the feasibility of using 3D translabial ultrasound imaging of the vagina at various distension volumes to predict the pessary size for successful fit. Ultrasound images will be obtained using commercially available 3D ultrasound probes (Philips, Netherlands), as well as a commercially available 2D ultrasound probe (Philips, Netherlands), which is linearly scanned to capture a 3D volume. The linear scanning will be performed by attaching the 2D probe to a motorized hand-held scanner, which is used to tilt and move the probe to acquire images. Please note that the hand-held scanner does not come in contact with the patient. To distend the vagina, a sterile bag is inserted in the vagina and gradually filled with water using a commercially available urodynamic system (Laborie, Canada) until the vaginal capacity is reached, without causing any discomfort to the patient. This image acquisition technique, previously reported in the literature, is referred to as 3D ultrasound vaginal manometry in this study. To achieve the objective of this project, 35 pelvic organ prolapse patients, who (i) are current pessary users, (ii) can perform self-care of the pessary, and (iii) can provide informed consent, will be invited to participate in the study. Patients will be asked to remove their pessary prior to ultrasound imaging. Then, 3D ultrasound vaginal manometry will be performed, using the technique described above. Ultrasound images will be analyzed once data acquisition is completed. The size of the pessary estimated from ultrasound images will be compared with the actual pessary size used by the patient.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 1, 2019

Completed
5 months until next milestone

First Posted

Study publicly available on registry

September 23, 2019

Completed
4 months until next milestone

Study Start

First participant enrolled

February 1, 2020

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 5, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2023

Completed
Last Updated

April 30, 2024

Status Verified

April 1, 2024

Enrollment Period

3.6 years

First QC Date

May 1, 2019

Last Update Submit

April 26, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • FEASIBILITY: The predicted pessary size

    The predicted pessary size in cubic mm will be compared with the actual size of the pessary used by the patient

    Up to 3 months following data collection

  • FEASIBILITY: The predicted pessary shape

    The predicted pessary shape will be compared with the actual shape of the pessary used by the patient by calculating the DICE coefficient.

    Up to 3 months following data collection

Study Arms (1)

Patients with Pelvic Organ Prolapse

OTHER

Patients who meet the inclusion criteria will be recruited. Ultrasound images of the pelvic floor and vaginal cavity will be analyzed to predict pessary size and type. This will be compared against the pessary size and type being used already by the patient.

Device: Ultrasound Imaging

Interventions

3D ultrasound of the pelvic floor and vaginal cavity will be obtained by using a commercial ultrasound system.

Patients with Pelvic Organ Prolapse

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPelvic organ prolapse only occurs in females.
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Current pessary users (\> 6 months) who have no pessary related complication, including discomfort, repeated vaginal bleeding, and pessary extrusion
  • Are able to provide informed consent
  • Can perform self-care, i.e. removing and inserting the pessary themselves
  • Are willing to remove their pessary 2 days before the ultrasound examination date.

You may not qualify if:

  • Inability to give informed consent
  • Inability to communicate with the person performing the consent and the sonographer performing ultrasound scanning
  • History of pelvic radiation or surgery, (including hysterectomy)
  • Using pessaries other than ring, incontinence dish, donut, Shaatz, Marland, or Gellhorn.
  • Inability to perform the Valsalva maneuver or pelvic floor contraction
  • Restricted mobility that prevents them from ambulating to assess the comfort level of the pessary during the initial pessary fitting visit.
  • Lack of sensation at the pelvic floor.
  • Being pregnant at the time of the examination.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Victoria Hospital

London, Ontario, N6A 5W9, Canada

Location

MeSH Terms

Conditions

Prolapse

Interventions

Ultrasonography

Condition Hierarchy (Ancestors)

Pathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 1, 2019

First Posted

September 23, 2019

Study Start

February 1, 2020

Primary Completion

September 5, 2023

Study Completion

November 1, 2023

Last Updated

April 30, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Data will be de-identified, and only the aggregate results will be used for publication. Patient information will not be made public or shared with researchers outside of the study team.

Locations